A detailed history of Sentinus, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sentinus, LLC holds 3,282 shares of MRK stock, worth $316,089. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,282
Previous 3,462 5.2%
Holding current value
$316,089
Previous $428,000 13.08%
% of portfolio
0.09%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $20,007 - $23,214
-180 Reduced 5.2%
3,282 $372,000
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $183,595 - $197,179
1,483 Added 74.94%
3,462 $428,000
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $6,341 - $7,389
-56 Reduced 2.75%
1,979 $261,000
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $23,242 - $25,333
-214 Reduced 9.52%
2,035 $234,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $231,512 - $258,320
2,249 New
2,249 $239,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sentinus, LLC Portfolio

Follow Sentinus, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentinus, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentinus, LLC with notifications on news.